Replay | Q4 FY26 Results Webinar
Orthocell has released the replay of its July investor webinar, in which Chair John Van Der Wielen, CEO and Managing Director Paul Anderson, CFO Jim Piper and VP U.S. Sales John Walker set out the strategy behind the Company’s record FY2026 results and the momentum building in its U.S. commercialisation of Remplir™. Insights from the webinar include: A foundation-first…
Orthocell delivers record quarterly and full-year revenue as global commercial momentum accelerates
Orthocell (ASX:OCC) has released its Quarterly Report for the quarter ended 30 June 2026, reporting record quarterly and full-year revenue, continued growth in the United States and further expansion across international markets. Key highlights from this quarter include: Orthocell delivered record quarterly revenue of $3.8 million, representing a 20% increase on the March quarter and a 36% increase…
Orthocell Appoints Exclusive Remplir™ Distributor for Thailand
Orthocell Limited (ASX: OCC) has appointed medical device distributor MediTime as its exclusive distributor for Remplir™ in Thailand, following regulatory approval from the Thai Food and Drug Administration to commence sales into an estimated US$84 million nerve repair market. MediTime is a specialist orthopaedics and sports medicine distributor with established coverage across Thailand’s leading hospitals, medical schools and regional centres, and a…
Orthocell featured in AusBiotech Spotlight series
Orthocell featured in AusBiotech Spotlight series Orthocell has been featured in AusBiotech’s Spotlight series, which profiles organisations and individuals contributing to Australia’s life sciences sector. The episode provides an overview of Orthocell’s work as an Australian regenerative medicine company developing medical technologies for bone, nerve and soft tissue repair. Orthocell’s portfolio includes cell therapies and collagen-based medical…
2026 Nerve Symposium
2026 Nerve Symposium: Supporting surgeon education and global collaboration in peripheral nerve repair Orthocell continued to support specialist surgeon education and global clinical collaboration through the 2026 Orthocell Nerve Symposium, held in Sydney. Now in its fourth year, the symposium has become an important forum for advancing discussion, education and practical experience in peripheral nerve…
Surgical Solutions for Peripheral Nerve Repair Dinner & Lecture
Orthocell hosted the Surgical Solutions for Peripheral Nerve Repair Dinner & Lecture in Perth this evening, proudly supported by our partners at Device Technologies. The Orthocell team has spent a busy few days with leading international surgeons, that are in Australia for the Orthocell Nerve Symposium on Friday in Sydney. Attending peripheral nerve cases; touring the Orthocell Ltd HQ; and…